nab-Paclitaxel-Based Regimens in Underserved Patient Populations Part 2: The ABOUND.PS2 Study in Patients with NSCLC and a Performance Status of 2 User montaukwhaler, in the non small cell lung cancer subreddit, 27 Jun 2018